Access denied: Leukemia thwarted by cutting off link to environmental support A protein's critical -- and previously unknown -- role in the development and progression of acute myeloid leukemia, a fast-growing and extremely difficult-to-treat blood cancer, has been revealed by researchers.
Researchers decode molecular action of combination therapy for a deadly thyroid cancer In their bid to find the best combination of therapies to treat anaplastic thyroid cancer, researchers have demonstrated that all histone deacetylase inhibitors are not created equal
Toxin from salmonid fish has potential to treat cancer Pathogenic bacteria develop killer machines that work very specifically and highly efficiently. Scientists have solved the molecular mechanism of a fish toxin that could be used in the future as a medication to treat cancer
Prostate cancer not caused by shift work, Shift work is widespread: between approximately one in five and one in six of the working population work shifts. Now new research shows, that in fact, shift workers do not develop prostate cancer more frequently than their colleagues who work during the day.
For prostate cancer patients, risk-specific therapies now more the norm After decades of over treatment for low-risk prostate cancer and inadequate management of its more aggressive forms, patients are now more likely to receive medical care matched to level of risk.
No comments:
Post a Comment